Literature DB >> 3157344

Therapeutic efficacy of teicoplanin in experimental enterococcal endocarditis.

P M Sullam, M G Täuber, C J Hackbarth, M A Sande.   

Abstract

The antimicrobial activities of teicoplanin and ampicillin, alone and in combination with gentamicin, were compared in experimental Streptococcus faecalis endocarditis. Bacterial titers in vegetations of rabbits treated with teicoplanin were significantly lower than those of untreated controls (P less than 0.01) and were equivalent to titers in ampicillin-treated animals. Gentamicin increased the activities of both drugs to a comparable degree.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3157344      PMCID： PMC176220          DOI： 10.1128/AAC.27.1.135

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  8 in total

1.  Resistance to six aminoglycosidic aminocyclitol antibiotics among enterococci: prevalence, evolution, and relationship to synergism with penicillin.

Authors:  S A Calderwood; C Wennersten; R C Moellering; L J Kunz; D J Krogstad
Journal:  Antimicrob Agents Chemother       Date:  1977-09       Impact factor: 5.191

2.  Simple method for elimination of aminoglycosides from serum to permit bioassay of other antimicrobial agents.

Authors:  P Stevens; L S Young
Journal:  Antimicrob Agents Chemother       Date:  1977-08       Impact factor: 5.191

3.  Comparison of the in vitro activities of teichomycin A2 and vancomycin against staphylococci and enterococci.

Authors:  M H Cynamon; P A Granato
Journal:  Antimicrob Agents Chemother       Date:  1982-03       Impact factor: 5.191

4.  A novel mechanism of resistance to penicillin-gentamicin synergism in Streptococcus faecalis.

Authors:  R C Moellering; B E Murray; S C Schoenbaum; J Adler; C B Wennersten
Journal:  J Infect Dis       Date:  1980-01       Impact factor: 5.226

5.  Species-specific resistance to antimocrobial synergism in Streptococcus faecium and Streptococcus faecalis.

Authors:  R C Moellering; O M Korzeniowski; M A Sande; C B Wennersten
Journal:  J Infect Dis       Date:  1979-08       Impact factor: 5.226

6.  Comparative in vitro activities of teichomycin and vancomycin alone and in combination with rifampin and aminoglycosides against staphylococci and enterococci.

Authors:  C U Tuazon; H Miller
Journal:  Antimicrob Agents Chemother       Date:  1984-04       Impact factor: 5.191

7.  High-level resistance to gentamicin in clinical isolates of enterococci.

Authors:  B D Mederski-Samoraj; B E Murray
Journal:  J Infect Dis       Date:  1983-04       Impact factor: 5.226

8.  Experimental endocarditis. II. Staphylococcal infection of the aortic valve following placement of a polyethylene catheter in the left side of the heart.

Authors:  B B Perlman; L R Freedman
Journal:  Yale J Biol Med       Date:  1971-10
  8 in total
  14 in total

Review 1.  Screening and treatment of infections caused by resistant enterococci.

Authors:  D J Herman; D N Gerding
Journal:  Antimicrob Agents Chemother       Date:  1991-02       Impact factor: 5.191

Review 2.  Current perspectives on glycopeptide resistance.

Authors:  N Woodford; A P Johnson; D Morrison; D C Speller
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

3.  Efficacy of teicoplanin-gentamicin given once a day on the basis of pharmacokinetics in humans for treatment of enterococcal experimental endocarditis.

Authors:  P López; J Gavaldà; M T Martin; B Almirante; X Gomis; C Azuaje; N Borrell; L Pou; V Falcó; C Pigrau; A Pahissa
Journal:  Antimicrob Agents Chemother       Date:  2001-05       Impact factor: 5.191

4.  Poor efficacy of teicoplanin in treatment of deep-seated staphylococcal infections.

Authors:  N Galanakis; H Giamarellou; N Vlachogiannis; C Dendrinos; G K Daikos
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-04       Impact factor: 3.267

5.  Pharmacokinetics of teicoplanin in critically ill patients with various degrees of renal impairment.

Authors:  Y Domart; C Pierre; B Clair; J J Garaud; B Regnier; C Gibert
Journal:  Antimicrob Agents Chemother       Date:  1987-10       Impact factor: 5.191

6.  The use of a new glycopeptide antibiotic, teicoplanin, in the treatment of bacterial endocarditis.

Authors:  A Webster; A P Wilson; A H Williams; T Treasure; R N Grüneberg
Journal:  Postgrad Med J       Date:  1987-08       Impact factor: 2.401

Review 7.  The epidemiology of enterococci.

Authors:  C Chenoweth; D Schaberg
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-02       Impact factor: 3.267

Review 8.  Therapy of enterococcal infections.

Authors:  G M Eliopoulos; C T Eliopoulos
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-02       Impact factor: 3.267

9.  Teicoplanin pharmacokinetics in intravenous drug abusers being treated for bacterial endocarditis.

Authors:  M J Rybak; S A Lerner; D P Levine; L M Albrecht; P L McNeil; G A Thompson; M T Kenny; L Yuh
Journal:  Antimicrob Agents Chemother       Date:  1991-04       Impact factor: 5.191

10.  Evaluation of teicoplanin for treatment of endocarditis caused by gram-positive cocci in 20 patients.

Authors:  C Leport; C Perronne; P Massip; P Canton; P Leclercq; E Bernard; P Lutun; J J Garaud; J L Vilde
Journal:  Antimicrob Agents Chemother       Date:  1989-06       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.